Peter Casasanto Email & Phone Number

Bend, OR, US

Pasadena, California, US

Rolle, CH

AI-enabled data driven insights to drive novel biomarker discovery, improve clinical trial performance and gain access to high-quality real world genomic + radiomic + clinical data. Global. Decentralized. Platform Agnostic.The SOPHiA DDM™ platform's data and predictive analytics capabilities leverage proprietary algorithms powering smart diagnostics and.

Montreal, Quebec, CA

Lead the Commercial strategies for new corporate initiatives, including companion diagnostics/single-site IVD, New SaaS Analytics product & Go To Market (CellEngine), Big Data, Multiomics & AI/MLPart of the M&A Deal Team for corporate development, due diligence, new technology evaluations, licensing, strategic partnerships

Chicago, IL, US

Drive the build-out and strategy of new Tempus Life Sciences ALPHA business unit in order to maximize customer return across the value chain. Nurture Strategic Partnerships, monetize Tempus assets and IP and promote market penetration through innovative deal structuring and negotiations, asset and portfolio valuation, risk analysis and financial modeling.

Chicago, IL, US

Making precision medicine a reality by leveraging machine learning/AI to gather, structure and analyze clinical and molecular data at scale. We create proprietary data sets for analyses across a wide variety of patient cohorts...enabling translational research, better trial design, patient recruitment, treatment-response and outcomes data, and FDA-grade.

Fort Myers, Florida, US

Drive continued growth of the Pharma Services division through strategic evaluations of new market opportunities, potential acquisitions, new technology evaluation, competitive market analysis and strategic partnershipsSupport overall growth strategy through end-to-end research, analysis, modeling and presentation delivery of M&A targetsContinue to drive.

Sr Director, Strategic Sales within Covance Central Labs, a division of LabCorp. Supporting Esoteric/Specialty Testing, Vaccines, Translational Biomarkers and Companion Diagnostics.Support CDx through all phases of development to commercial launch, including IVD & LDT development and clinical trials testing support through to PMA/510KGenomics Services.

Key Account Director, Strategic Sales within LabCorp Clinical Trials division, supporting Central Lab, Esoteric/Specialty Testing, Translational Biomarkers and Companion Diagnostics.Labcorp Genomics Services (Next-Gen Sequencing, DNA-seq, RNA-seq, miRNA profiling, gene expression, translational Biomarkers and liquid biopsy CTC)Monogram Biosciences.

Wilmington, NC, US

Strategic partner for vaccines and bioanalytical assay development, clinical testing services and post-approval expertise to support pharmaceutical, vaccines and biologics commercialization efforts. Identify, target and develop opportunistic leads, extend product reach, professionally present capabilities, manage the sales process through close and handle.

Program Management Group, responsible for the development, optimization and validation of vaccine immunoassays used as primary efficacy biomarkers in support of several Phase II/III viral and bacterial programs. Experience in cell-based and multiplexed (Flow, Luminex) assay development and clinical testing. Major focus on FACS-based, total IgG and.

Philadelphia, Pennsylvania, US

Master's Thesis: Monitoring the Role of Tissue Factor, Cholesterol and the Fcgamma Receptor in Arteriosclerosis/Thrombosis & Vascular Biology.Cholesterol Enrichment of Human Monocyte/Macrophages Induces Surface Exposure of Phosphatidylserine and the Release of Biologically-Active Tissue Factor Microvesicles. Arterioscler Thromb Vasc Biol 2007;27;430-435;

Mba, Pharmaceutical Management

Master Of Science, Biomedical Chemistry

Bachelor Of Science, Molecular Biology And Genetics